Impact of smoking cessation and smoking interventions in patients with coronary heart disease

European Heart Journal

Volumn 20, Issue 24, 1999, Pages 1773-1782

  Van Berkel, T F M ^a   Boersma, H ^a   Roos Hesselink, J W ^a   Erdman, R A M ^a   Simoons, M L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING CESSATION; STATISTICAL ANALYSIS; SUBSTITUTION THERAPY;

CLINICAL TRIALS; CORONARY DISEASE; HUMANS; INCIDENCE; PROGNOSIS; RECURRENCE; SMOKING; SMOKING CESSATION; SURVIVAL RATE;

EID: 0032785013     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1658     Document Type: Review

References (61)

1. U.S. Department of Health and Human Services. The health consequences of smoking: cardiovascular disease. A report of the Surgeon general's office on smoking & health. Rockville, Maryland: DHHS (PHS), 90-50204,1990. 1990.
2. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors [see comments]. Br Med J 1994; 309: 901-11.
3. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998; 19: 1434-503.
4. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997; 96: 3243-7.
5. Anonymous. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997; 18: 1569-82.
6. Wilhelmsson C, Vedin JA, Elmfeldt D, Tibblin G, Wilhelmsen L. Smoking and myocardial infarction. Lancet 1975; 1: 415-20.
7. Mulcahy R, Hickey N, Graham IM, MacAirt J. Factors affecting the 5 year survival rate of men following acute coronary heart disease. Am Heart J 1977; 93: 556-9.
8. Sparrow D, Dawber TR. The influence of cigarette smoking on prognosis after a first myocardial infarction. A report from the Framingham study. J Chronic Dis 1978; 31: 425-32.
9. Salonen JT. Stopping smoking and long-term mortality after acute myocardial infarction. Br Heart J 1980; 43: 463-9.
10. Aberg A, Bergstrand R, Johansson S, Ulvenstam G, Vedin A, Wedel H et al. Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J 1983; 49: 416-22.
11. Daly LE, Mulcahy R, Graham IM, Hickey N. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J 1983; 287: 324-6.
12. Ronnevik PK, Gundersen T, Abrahamsen AM. Effect of smoking habits and timolol treatment on mortality and reinfarction in patients surviving acute myocardial infarction. Br Heart J 1985; 54: 134-9.
13. Perkins J, Dick TB. Smoking and myocardial infarction: secondary prevention. Postgrad Med J 1985; 61: 295-300.
14. Johansson S, Bergstrand R, Pennert K et al. Cessation of smoking after myocardial infarction in women. Effects on mortality and reinfarctions. Am J Epidemiol 1985; 121: 823-31.
15. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986; 314: 271-5.
16. Vlietstra RE, Kronmal RA, Oberman A, Frye RL, Killip TD. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA 1986; 255: 1023-7.
17. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry [see comments]. N Engl J Med 1988; 319: 1365-9.
18. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol 1992; 20: 287-94.
19. Sato I, Nishida M, Okita K et al. Beneficial effect of stopping smoking on future cardiac events in male smokers with previous myocardial infarction. Jpn Circ J 1992; 56: 217-22.
20. Gupta R, Gupta KD, Sharma S, Gupta VP. Influence of cessation of smoking on long term mortality in patients with coronary heart disease. Indian Heart J 1993; 45: 125-9.
21. Herlitz J, Bengtson A, Hjalmarson A, Karlson BW. Smoking habits in consecutive patients with acute myocardial infarction: prognosis in relation to other risk indicators and to whether or not they quit smoking. Cardiology 1995; 86: 496-502.
22. Greenwood DC, Muir KR, Packham CJ, Madeley RJ. Stress, social support, and stopping smoking after myocardial infarction in England. J Epidemiol Community Health 1995; 49: 583-7.
23. Voors AA, van Brussel BL, Plokker HW et al. Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. Circulation 1996; 93: 42-7.
24. Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes D, Jr. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997; 336: 755-61.
25. Galan KM, Deligonul U, Kern MJ, Chaitman BR, Vandormael MG. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988; 61: 260-3.
26. Miwa K, Fujita M, Miyagi Y. Beneficial effects of smoking cessation on the short-term prognosis for variant angina - validation of the smoking status by urinary cotinine measurements. Int J Cardiol 1994; 44: 151-6.
27. Burt A, Thornley P, Illingworth D, White P, Shaw TR, Turner R. Stopping smoking after myocardial infarction. Lancet 1974; 1: 304-6.
28. Pozen MW, Stechmiller JA, Harris W, Smith S, Fried DD, Voigt GC. A nurse rehabilitator's impact on patients with myocardial infarction. Med Care 1977; 15: 830-7.
29. Barr Taylor C, Houston-Miller N, Killen JD, DeBusk RF. Smoking cessation after Acute Myocardial Infarction: Effects of a Nurse-Managed Intervention. Ann Intern Med 1990; 113: 118-23.
30. DeBusk RF, Miller NH, Superko HR et al. A case-management system for coronary risk factor modification after acute myocardial infarction [see comments]. Ann Intern Med 1994; 120: 721-9.
31. Carlsson R, Lindberg G, Westin L, Israelsson B. Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction. Heart 1997; 77: 256-9.
32. Engblom E, Ronnemaa T, Hamalainen H, Kallio V, Vanttinen E, Knuts LR. Coronary heart disease risk factors before and after bypass surgery: results of a controlled trial on multifactorial rehabilitation. Eur Heart J 1992; 13: 232-7.
33. Rigotti NA, McKool KM, Shiffman S. Predictors of smoking cessation after coronary artery bypass graft surgery. Results of a randomized trial with 5-year follow-up. Ann Intern Med 1994; 120: 287-93.
34. Ockene J, Kristeller JL, Goldberg R et al. Smoking cessation and severity of disease: the Coronary Artery Smoking Intervention Study. Health Psychol 1992; 11: 119-26.
35. Haskell WL, Alderman EL, Fair JM et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89: 975-90.
36. Johnson JL, Budz B, Mackay M, Miller C. Evaluation of a nurse-delivered smoking cessation intervention for hospitalized patients with cardiac disease. Heart Lung 1999; 28: 55-64.
37. Benowitz NL. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 1988; 319: 1318-30.
38. Allred EN, Bleecker ER, Chaitman BR et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease [published erratum appears in N Engl J Med 1990 Apr 5;322(14):1019] [see comments]. N Engl J Med 1989; 321: 1426-32.
39. Allen SS, Hatsukami D, Gorsline J. Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group. Prev Med 1994; 23: 190-6.
40. Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. Br Med J 1979; 2: 231-5.
41. Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981; 2: 1303-10.
42. Kottke TE, Battista RN, DeFriese GH, Brekke ML. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA 1988; 259: 2883-9.
43. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139-42.
44. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997; 29: 1422-31.
45. Anonymous. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease. Arch Intern Med 1994; 154: 989-95.
46. Joseph AM, Norman SM, Ferry LH et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335: 1792-8.
47. Ockene JK, Hosmer D, Rippe J et al. Factors affecting cigarette smoking status in patients with ischemic heart disease. J Chronic Dis 1985; 38: 985-94.
48. Frid D, Ockene IS, Ockene JK et al. Severity of angiographically proven coronary artery disease predicts smoking cessation. Am J Prev Med 1991; 7: 131-5.
49. Freund KM, D'Agostino RB, Belanger AJ, Kannel WB, Stokes JD. Predictors of smoking cessation: the Framingham Study. Am J Epidemiol 1992; 135: 957-64.
50. Di Tullio M, Granata D, Taioli E et al. Early predictors of smoking cessation after myocardial infarction. Clin Cardiol 1991; 14: 809-12.
51. Baile W, Jr., Bigelow GE, Gottlieb SH, Stitzer ML, Sacktor JD. Rapid resumption of cigarette smoking following myocardial infarction: inverse relation to MI severity. Addict Behav 1982; 7: 373-80.
52. Hasdai D, Garratt KN, Grill DE et al. Predictors of smoking cessation after percutaneous coronary revascularization [see comments]. Mayo Clin Proc 1998; 73: 205-9.
53. Huijbrechts IPAM, Duivenvoorden HJ, Deckers JW et al. Modification or smoking habits five months after myocardial infarction: relationship with personality characteristics. J Psychosomatic Res 1996; 40: 369-78.
54. Glassman AH, Stetner F, Walsh BT et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 1988; 259: 2863-6.
55. Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res 1988; 32: 159-64.
56. Schleifer SJ, Macari-Hinson MM, Coyle DA et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149: 1785-9.
57. Littman AB. Review of psychosomatic aspects of cardiovascular disease. [Review]. Psychother Psychosom 1993; 60: 148-67.
58. Roose SP, Laghrissi-Thode F, Kennedy JS et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998; 279: 287-91.
59. Jorenby DE, Leischow SJ, Nides MA et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-91.
60. Prochaska JO, Goldstein MG. Process of smoking cessation. Implications for clinicians. Clin Chest Med 1991; 12: 727-35.
61. Rice VH, Templin T, Fox DH et al. Social context variables as predictors of smoking cessation. Tob Control 1996; 5: 280-5.